BKT-1120

N/A

Report date: 2025/12/17 17:47:44

Base Information

Drug NameBKT-1120
Drug Alias NameBKT-1120BKT1120
ClassificationOther
Mechanisms of ActionEukaryotic translation initiation factor 2-alpha kinase 4 modulators
TargetsEukaryotic translation initiation factor 2-alpha kinase 4
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBaerenkraft Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesBaerenkraft Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A